Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| CG ONCOLOGY INC(CGON) | 6,371,669 | 6,371,669 | 0 | 264,552 | 431,235 | 65.21% | +166,683 |
| Aclaris Therapeutics, Inc.(ACRS) | 4,041,736 | 4,041,736 | 0 | 12,166 | 15,157 | 2.29% | +2,991 |
| Equillium Inc.(EQ) | 4,447,308 | 4,447,308 | 0 | 6,893 | 8,895 | 1.34% | +2,001 |
| Zentalis Pharmaceuticals Inc.(ZNTL) | 1,323,327 | 1,323,327 | 0 | 1,786 | 3,097 | 0.47% | +1,310 |
| Pyxis Oncology, Inc (formerly Apexigen)(PYXS) | 326,810 | 326,810 | 0 | 376 | 477 | 0.07% | +101 |
| BeyondSpring Inc.(BYSI) | 3,800,702 | 3,800,702 | 0 | 6,195 | 6,233 | 0.94% | +38 |
| REZOLUTE INC(RZLT) | 59,900 | 0 | -59,900 | 141 | 0 | — | -141 |
| Nuvation Bio Inc.(NUVB) | 646,057 | 0 | -646,057 | 213 | 0 | — | -213 |
| 4D MOLECULAR THERAPEUTICS IN | 44,311 | 0 | -44,311 | 332 | 0 | — | -332 |
| Aura Biosciences, Inc.(AURA) | 360,483 | 0 | -360,483 | 1,965 | 0 | — | -1,965 |
| KRYSTAL BIOTECH INC(KRYS) | 17,300 | 7,300 | -10,000 | 4,265 | 1,886 | 0.29% | -2,379 |
| Arcus Biosciences, Inc(RCUS) | 541,559 | 477,819 | -63,740 | 12,905 | 10,321 | 1.56% | -2,584 |
| CRINETICS PHARMACEUTICALS IN(CRNX) | 92,700 | 0 | -92,700 | 4,315 | 0 | — | -4,315 |
| REVOLUTION MEDICINES INC(NSM)(RVMD) | 200,000 | 93,500 | -106,500 | 15,930 | 9,093 | 1.37% | -6,837 |
| Lyell Immunopharma, Inc.(LYEL) | 692,050 | 692,050 | 0 | 21,301 | 13,883 | 2.10% | -7,419 |
| NEWAMSTERDAM PHARMA CO NV ORDINARY SHARES | 592,057 | 325,057 | -267,000 | 20,769 | 10,405 | 1.57% | -10,364 |
| AARDVARK THERAPEUTICS INC | 3,917,299 | 3,917,299 | 0 | 51,415 | 14,768 | 2.23% | -36,646 |
| Upstream Bio Inc.(UPB) | 3,143,078 | 2,724,868 | -418,210 | 85,335 | 24,524 | 3.71% | -60,811 |
| Nuvation Bio Inc.(NUVB) | 25,954,439 | 25,954,439 | 0 | 232,552 | 111,345 | 16.84% | -121,207 |